610 related articles for article (PubMed ID: 33713739)
41. Methods to detect endogenous dsRNA induction and recognition.
Ettayebi I; Yau HL; De Carvalho DD
Methods Enzymol; 2019; 629():35-51. PubMed ID: 31727248
[TBL] [Abstract][Full Text] [Related]
42. Synergy between RA and TLR3 promotes type I IFN-dependent apoptosis through upregulation of TRAIL pathway in breast cancer cells.
Bernardo AR; Cosgaya JM; Aranda A; Jiménez-Lara AM
Cell Death Dis; 2013 Jan; 4(1):e479. PubMed ID: 23370279
[TBL] [Abstract][Full Text] [Related]
43. Suppression of dsRNA response genes and innate immunity following Oct4, Stella, and Nanos2 overexpression in mouse embryonic fibroblasts.
Farshchian M; Matin MM; Armant O; Geerts D; Dastpak M; Nakhaei-Rad S; Tajeran M; Jebelli A; Shahriyari M; Bahrami M; Fallah A; Yaghoobi V; Mirahmadi M; Abbaszadegan MR; Bahrami AR
Cytokine; 2018 Jun; 106():1-11. PubMed ID: 29501710
[TBL] [Abstract][Full Text] [Related]
44. p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs.
Leonova KI; Brodsky L; Lipchick B; Pal M; Novototskaya L; Chenchik AA; Sen GC; Komarova EA; Gudkov AV
Proc Natl Acad Sci U S A; 2013 Jan; 110(1):E89-98. PubMed ID: 23236145
[TBL] [Abstract][Full Text] [Related]
45. Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature.
Rice GI; Kasher PR; Forte GM; Mannion NM; Greenwood SM; Szynkiewicz M; Dickerson JE; Bhaskar SS; Zampini M; Briggs TA; Jenkinson EM; Bacino CA; Battini R; Bertini E; Brogan PA; Brueton LA; Carpanelli M; De Laet C; de Lonlay P; del Toro M; Desguerre I; Fazzi E; Garcia-Cazorla A; Heiberg A; Kawaguchi M; Kumar R; Lin JP; Lourenco CM; Male AM; Marques W; Mignot C; Olivieri I; Orcesi S; Prabhakar P; Rasmussen M; Robinson RA; Rozenberg F; Schmidt JL; Steindl K; Tan TY; van der Merwe WG; Vanderver A; Vassallo G; Wakeling EL; Wassmer E; Whittaker E; Livingston JH; Lebon P; Suzuki T; McLaughlin PJ; Keegan LP; O'Connell MA; Lovell SC; Crow YJ
Nat Genet; 2012 Nov; 44(11):1243-8. PubMed ID: 23001123
[TBL] [Abstract][Full Text] [Related]
46. Melanoma suppression by quercein is correlated with RIG-I and type I interferon signaling.
Peng D; Chen L; Sun Y; Sun L; Yin Q; Deng S; Niu L; Lou F; Wang Z; Xu Z; Wang C; Fan L; Wang H; Wang H
Biomed Pharmacother; 2020 May; 125():109984. PubMed ID: 32066042
[TBL] [Abstract][Full Text] [Related]
47. Double-stranded RNA induces biphasic STAT1 phosphorylation by both type I interferon (IFN)-dependent and type I IFN-independent pathways.
Dempoya J; Matsumiya T; Imaizumi T; Hayakari R; Xing F; Yoshida H; Okumura K; Satoh K
J Virol; 2012 Dec; 86(23):12760-9. PubMed ID: 22973045
[TBL] [Abstract][Full Text] [Related]
48. Activation of interferon-stimulated genes by gamma-ray irradiation independently of the ataxia telangiectasia mutated-p53 pathway.
Sugihara T; Murano H; Nakamura M; Ichinohe K; Tanaka K
Mol Cancer Res; 2011 Apr; 9(4):476-84. PubMed ID: 21357441
[TBL] [Abstract][Full Text] [Related]
49. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
[TBL] [Abstract][Full Text] [Related]
50. Double-stranded DNA and double-stranded RNA induce a common antiviral signaling pathway in human cells.
Cheng G; Zhong J; Chung J; Chisari FV
Proc Natl Acad Sci U S A; 2007 May; 104(21):9035-40. PubMed ID: 17517627
[TBL] [Abstract][Full Text] [Related]
51. Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma.
Napolitano A; Pellegrini L; Dey A; Larson D; Tanji M; Flores EG; Kendrick B; Lapid D; Powers A; Kanodia S; Pastorino S; Pass HI; Dixit V; Yang H; Carbone M
Oncogene; 2016 Apr; 35(15):1996-2002. PubMed ID: 26119930
[TBL] [Abstract][Full Text] [Related]
52. SETDB1 Restrains Endogenous Retrovirus Expression and Antitumor Immunity during Radiotherapy.
Pan D; Bao X; Hu M; Jiao M; Li F; Li CY
Cancer Res; 2022 Aug; 82(15):2748-2760. PubMed ID: 35648422
[TBL] [Abstract][Full Text] [Related]
53. Inflammation-Related IL1β/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma.
Kadariya Y; Menges CW; Talarchek J; Cai KQ; Klein-Szanto AJ; Pietrofesa RA; Christofidou-Solomidou M; Cheung M; Mossman BT; Shukla A; Testa JR
Cancer Prev Res (Phila); 2016 May; 9(5):406-414. PubMed ID: 26935421
[TBL] [Abstract][Full Text] [Related]
54. Interleukin-6 expression was regulated by epigenetic mechanisms in response to influenza virus infection or dsRNA treatment.
Tang B; Zhao R; Sun Y; Zhu Y; Zhong J; Zhao G; Zhu N
Mol Immunol; 2011 Apr; 48(8):1001-8. PubMed ID: 21353307
[TBL] [Abstract][Full Text] [Related]
55. Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma.
Bensaid D; Blondy T; Deshayes S; Dehame V; Bertrand P; Grégoire M; Errami M; Blanquart C
Clin Epigenetics; 2018; 10():79. PubMed ID: 29946373
[TBL] [Abstract][Full Text] [Related]
56. [Respiratory malignancies induced by asbestos exposure and evaluation of cases with typical pleural malignant mesothelioma and lung cancer with asbestosis].
Kishimoto T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Aug; 28(8):1078-84. PubMed ID: 2243458
[TBL] [Abstract][Full Text] [Related]
57. Studies of endogenous retroviruses reveal a continuing evolutionary saga.
Stoye JP
Nat Rev Microbiol; 2012 May; 10(6):395-406. PubMed ID: 22565131
[TBL] [Abstract][Full Text] [Related]
58. [Methylation and demethylation of SOX2 gene promoter in BGC-823 gastric cancer cells].
Wei B; Liu G; Cai HL; Li GP; Huang HQ; Luo Q; Huang ZJ
Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(32):2548-53. PubMed ID: 27596549
[TBL] [Abstract][Full Text] [Related]
59. Human endogenous retroviruses: friend or foe?
Weiss RA
APMIS; 2016; 124(1-2):4-10. PubMed ID: 26818257
[TBL] [Abstract][Full Text] [Related]
60. NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction.
Sasai M; Shingai M; Funami K; Yoneyama M; Fujita T; Matsumoto M; Seya T
J Immunol; 2006 Dec; 177(12):8676-83. PubMed ID: 17142768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
